Bristol-Myers pays SEC $14 million for bribery in China
US drugmaker Bristol-Myers Squibb is paying $14 million to the US SEC to settle charges that its Chinese joint venture violated the FCPA by allegedly making improper payments to hospital officials to boost drug sales.
In the news: Bristol-Myers pays $14 million FCPA fine, Xiaomi gets investigated for advertising violations, Unisplendor acquires Western Digital stake
This week US drugmaker Bristol-Myers Squibb paid the SEC to settle China bribery charges, Xiaomi faced accusations of violating the new Advertising Law and Tsinghua Unigroup paid $3.8 billion for Western Digital shares
By
clpstaff
& clp articles